Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose Influenza Vaccine Boosting in Solid Organ Transplant Recipients
NCT05663463Completed
- Sponsor
- University of Minnesota
- Start
- Sep 2023
- Primary completion
- Jun 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, double-blind trial of influenza virus vaccine, split virion in influenza (2 arms), sponsored by University of Minnesota. Primary endpoint: Neutralizing antibody levels - Immunogenicity. Started Sep 2023; status: completed.
02
Drugs
influenza virus vaccine, split virion
03
Conditions
influenza
Beyond the preview
Go deeper on NCT05663463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05663463.